Thymalfasin, a promising adjuvant therapy in small hepatocellular carcinoma after liver resection. [electronic resource]
Producer: 20170509Description: e6606 p. digitalISSN:- 1536-5964
- Adult
- Age Factors
- Aged
- Antineoplastic Agents -- administration & dosage
- Carcinoma, Hepatocellular -- drug therapy
- Chemotherapy, Adjuvant -- methods
- Comorbidity
- Disease-Free Survival
- Female
- Humans
- Liver Neoplasms -- drug therapy
- Male
- Middle Aged
- Neoplasm Staging
- Prognosis
- Proportional Hazards Models
- Retrospective Studies
- Sex Factors
- Thymalfasin
- Thymosin -- administration & dosage
- Young Adult
No physical items for this record
Publication Type: Journal Article; Observational Study
There are no comments on this title.
Log in to your account to post a comment.